Presenting signs and patient co-variables in Gaucher disease: outcome of the Gaucher Earlier Diagnosis Consensus (GED-C) Delphi initiative

Autores
Mehta, Atul; Kuter, David J.; Salek, Sam S.; Belmatoug, Nadia; Bembi, Bruno; Bright, Jeremy; vom Dahl, Stephan; Deodato, Federica; Di Rocco, Maja; Göker Alpan, Ozlem; Hughes, Derralynn A.; Lukina, Elena A.; Machaczka, Maciej; Mengel, Eugen; Nagral, Aabha; Nakamura, Kimitoshi; Narita, Aya; Oliveri, María Beatriz; Pastores, Gregory; Pérez-López, Jordi; Ramaswami, Uma; Schwartz, Ida V.; Szer, Jeff; Weinreb, Neal J.; Zimran, Ari
Año de publicación
2019
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
Background: Gaucher disease (GD) presents with a range of signs and symptoms. Physicians can fail to recognise the early stages of GD owing to a lack of disease awareness, which can lead to significant diagnostic delays and sometimes irreversible but avoidable morbidities. Aim: The Gaucher Earlier Diagnosis Consensus (GED-C) initiative aimed to identify signs and co-variables considered most indicative of early type 1 and type 3 GD, to help non-specialists identify ‘at-risk’ patients who may benefit from diagnostic testing. Methods: An anonymous, three-round Delphi consensus process was deployed among a global panel of 22 specialists in GD (median experience 17.5 years, collectively managing almost 3000 patients). The rounds entailed data gathering, then importance ranking and establishment of consensus, using 5-point Likert scales and scoring thresholds defined a priori. Results: For type 1 disease, seven major signs (splenomegaly, thrombocytopenia, bone-related manifestations, anaemia, hyperferritinaemia, hepatomegaly and gammopathy) and two major co-variables (family history of GD and Ashkenazi-Jewish ancestry) were identified. For type 3 disease, nine major signs (splenomegaly, oculomotor disturbances, thrombocytopenia, epilepsy, anaemia, hepatomegaly, bone pain, motor disturbances and kyphosis) and one major co-variable (family history of GD) were identified. Lack of disease awareness, overlooking mild early signs and failure to consider GD as a diagnostic differential were considered major barriers to early diagnosis. Conclusion: The signs and co-variables identified in the GED-C initiative as potentially indicative of early GD will help to guide non-specialists and raise their index of suspicion in identifying patients potentially suitable for diagnostic testing for GD.
Fil: Mehta, Atul. University of California at Los Angeles; Estados Unidos
Fil: Kuter, David J.. Harvard Medical School; Estados Unidos
Fil: Salek, Sam S.. University Of Hertfordshire; Reino Unido
Fil: Belmatoug, Nadia. University Hospital Paris Nord Val de Seine.Referral Center for Lysosomal Diseases; Francia
Fil: Bembi, Bruno. Academic Medical Centre Hospital of Udine; Italia
Fil: Bright, Jeremy. Oxford PharmaGenesis Ltd. Research Evaluation Unit; Reino Unido
Fil: vom Dahl, Stephan. Heinrich-Heine University; Alemania
Fil: Deodato, Federica. Bambino Gesù Children’s Hospital; Italia
Fil: Di Rocco, Maja. Istituto Giannina Gaslini; Italia
Fil: Göker Alpan, Ozlem. No especifíca;
Fil: Hughes, Derralynn A.. University of California at Los Angeles; Estados Unidos
Fil: Lukina, Elena A.. National Research Center for Hematology; Rusia
Fil: Machaczka, Maciej. University Of Rzeszów; Polonia. Karolinska University Hospital Huddinge; Suecia
Fil: Mengel, Eugen. Johannes Gutenberg Universitat Mainz; Alemania
Fil: Nagral, Aabha. Apollo Hospital; India
Fil: Nakamura, Kimitoshi. Kumamoto University; Japón
Fil: Narita, Aya. Tottori University. Faculty Of Medicine; Japón
Fil: Oliveri, María Beatriz. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Inmunología, Genética y Metabolismo. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Inmunología, Genética y Metabolismo; Argentina
Fil: Pastores, Gregory. The Mater Misericordiae University Hospital; Irlanda
Fil: Pérez-López, Jordi. Hospital Vall d’Hebron; España
Fil: Ramaswami, Uma. Universidade Federal do Rio Grande do Sul; Brasil
Fil: Schwartz, Ida V.. Universidade Federal do Rio Grande do Sul; Brasil
Fil: Szer, Jeff. The Royal Melbourne Hospital; Australia
Fil: Weinreb, Neal J.. University of Miami; Estados Unidos
Fil: Zimran, Ari. Shaare Zedek Medical Center; Israel. Hadassah Medical School; Israel
Materia
ALGORITHM
INBORN ERROR
LYSOSOMAL STORAGE DISEASE
METABOLISM
SPLENOMEGALY
THROMBOCYTOPENIA
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by-nc-nd/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/116167

id CONICETDig_c918e3512463cf3814cc3456e1a59c7d
oai_identifier_str oai:ri.conicet.gov.ar:11336/116167
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling Presenting signs and patient co-variables in Gaucher disease: outcome of the Gaucher Earlier Diagnosis Consensus (GED-C) Delphi initiativeMehta, AtulKuter, David J.Salek, Sam S.Belmatoug, NadiaBembi, BrunoBright, Jeremyvom Dahl, StephanDeodato, FedericaDi Rocco, MajaGöker Alpan, OzlemHughes, Derralynn A.Lukina, Elena A.Machaczka, MaciejMengel, EugenNagral, AabhaNakamura, KimitoshiNarita, AyaOliveri, María BeatrizPastores, GregoryPérez-López, JordiRamaswami, UmaSchwartz, Ida V.Szer, JeffWeinreb, Neal J.Zimran, AriALGORITHMINBORN ERRORLYSOSOMAL STORAGE DISEASEMETABOLISMSPLENOMEGALYTHROMBOCYTOPENIAhttps://purl.org/becyt/ford/3.2https://purl.org/becyt/ford/3Background: Gaucher disease (GD) presents with a range of signs and symptoms. Physicians can fail to recognise the early stages of GD owing to a lack of disease awareness, which can lead to significant diagnostic delays and sometimes irreversible but avoidable morbidities. Aim: The Gaucher Earlier Diagnosis Consensus (GED-C) initiative aimed to identify signs and co-variables considered most indicative of early type 1 and type 3 GD, to help non-specialists identify ‘at-risk’ patients who may benefit from diagnostic testing. Methods: An anonymous, three-round Delphi consensus process was deployed among a global panel of 22 specialists in GD (median experience 17.5 years, collectively managing almost 3000 patients). The rounds entailed data gathering, then importance ranking and establishment of consensus, using 5-point Likert scales and scoring thresholds defined a priori. Results: For type 1 disease, seven major signs (splenomegaly, thrombocytopenia, bone-related manifestations, anaemia, hyperferritinaemia, hepatomegaly and gammopathy) and two major co-variables (family history of GD and Ashkenazi-Jewish ancestry) were identified. For type 3 disease, nine major signs (splenomegaly, oculomotor disturbances, thrombocytopenia, epilepsy, anaemia, hepatomegaly, bone pain, motor disturbances and kyphosis) and one major co-variable (family history of GD) were identified. Lack of disease awareness, overlooking mild early signs and failure to consider GD as a diagnostic differential were considered major barriers to early diagnosis. Conclusion: The signs and co-variables identified in the GED-C initiative as potentially indicative of early GD will help to guide non-specialists and raise their index of suspicion in identifying patients potentially suitable for diagnostic testing for GD.Fil: Mehta, Atul. University of California at Los Angeles; Estados UnidosFil: Kuter, David J.. Harvard Medical School; Estados UnidosFil: Salek, Sam S.. University Of Hertfordshire; Reino UnidoFil: Belmatoug, Nadia. University Hospital Paris Nord Val de Seine.Referral Center for Lysosomal Diseases; FranciaFil: Bembi, Bruno. Academic Medical Centre Hospital of Udine; ItaliaFil: Bright, Jeremy. Oxford PharmaGenesis Ltd. Research Evaluation Unit; Reino UnidoFil: vom Dahl, Stephan. Heinrich-Heine University; AlemaniaFil: Deodato, Federica. Bambino Gesù Children’s Hospital; ItaliaFil: Di Rocco, Maja. Istituto Giannina Gaslini; ItaliaFil: Göker Alpan, Ozlem. No especifíca;Fil: Hughes, Derralynn A.. University of California at Los Angeles; Estados UnidosFil: Lukina, Elena A.. National Research Center for Hematology; RusiaFil: Machaczka, Maciej. University Of Rzeszów; Polonia. Karolinska University Hospital Huddinge; SueciaFil: Mengel, Eugen. Johannes Gutenberg Universitat Mainz; AlemaniaFil: Nagral, Aabha. Apollo Hospital; IndiaFil: Nakamura, Kimitoshi. Kumamoto University; JapónFil: Narita, Aya. Tottori University. Faculty Of Medicine; JapónFil: Oliveri, María Beatriz. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Inmunología, Genética y Metabolismo. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Inmunología, Genética y Metabolismo; ArgentinaFil: Pastores, Gregory. The Mater Misericordiae University Hospital; IrlandaFil: Pérez-López, Jordi. Hospital Vall d’Hebron; EspañaFil: Ramaswami, Uma. Universidade Federal do Rio Grande do Sul; BrasilFil: Schwartz, Ida V.. Universidade Federal do Rio Grande do Sul; BrasilFil: Szer, Jeff. The Royal Melbourne Hospital; AustraliaFil: Weinreb, Neal J.. University of Miami; Estados UnidosFil: Zimran, Ari. Shaare Zedek Medical Center; Israel. Hadassah Medical School; IsraelWiley Blackwell Publishing, Inc2019-05info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/116167Mehta, Atul; Kuter, David J.; Salek, Sam S.; Belmatoug, Nadia; Bembi, Bruno; et al.; Presenting signs and patient co-variables in Gaucher disease: outcome of the Gaucher Earlier Diagnosis Consensus (GED-C) Delphi initiative; Wiley Blackwell Publishing, Inc; Internal Medicine Journal; 49; 5; 5-2019; 578-5911444-0903CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://onlinelibrary.wiley.com/doi/abs/10.1111/imj.14156info:eu-repo/semantics/altIdentifier/doi/10.1111/imj.14156info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-nd/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-29T09:35:06Zoai:ri.conicet.gov.ar:11336/116167instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-29 09:35:07.221CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv Presenting signs and patient co-variables in Gaucher disease: outcome of the Gaucher Earlier Diagnosis Consensus (GED-C) Delphi initiative
title Presenting signs and patient co-variables in Gaucher disease: outcome of the Gaucher Earlier Diagnosis Consensus (GED-C) Delphi initiative
spellingShingle Presenting signs and patient co-variables in Gaucher disease: outcome of the Gaucher Earlier Diagnosis Consensus (GED-C) Delphi initiative
Mehta, Atul
ALGORITHM
INBORN ERROR
LYSOSOMAL STORAGE DISEASE
METABOLISM
SPLENOMEGALY
THROMBOCYTOPENIA
title_short Presenting signs and patient co-variables in Gaucher disease: outcome of the Gaucher Earlier Diagnosis Consensus (GED-C) Delphi initiative
title_full Presenting signs and patient co-variables in Gaucher disease: outcome of the Gaucher Earlier Diagnosis Consensus (GED-C) Delphi initiative
title_fullStr Presenting signs and patient co-variables in Gaucher disease: outcome of the Gaucher Earlier Diagnosis Consensus (GED-C) Delphi initiative
title_full_unstemmed Presenting signs and patient co-variables in Gaucher disease: outcome of the Gaucher Earlier Diagnosis Consensus (GED-C) Delphi initiative
title_sort Presenting signs and patient co-variables in Gaucher disease: outcome of the Gaucher Earlier Diagnosis Consensus (GED-C) Delphi initiative
dc.creator.none.fl_str_mv Mehta, Atul
Kuter, David J.
Salek, Sam S.
Belmatoug, Nadia
Bembi, Bruno
Bright, Jeremy
vom Dahl, Stephan
Deodato, Federica
Di Rocco, Maja
Göker Alpan, Ozlem
Hughes, Derralynn A.
Lukina, Elena A.
Machaczka, Maciej
Mengel, Eugen
Nagral, Aabha
Nakamura, Kimitoshi
Narita, Aya
Oliveri, María Beatriz
Pastores, Gregory
Pérez-López, Jordi
Ramaswami, Uma
Schwartz, Ida V.
Szer, Jeff
Weinreb, Neal J.
Zimran, Ari
author Mehta, Atul
author_facet Mehta, Atul
Kuter, David J.
Salek, Sam S.
Belmatoug, Nadia
Bembi, Bruno
Bright, Jeremy
vom Dahl, Stephan
Deodato, Federica
Di Rocco, Maja
Göker Alpan, Ozlem
Hughes, Derralynn A.
Lukina, Elena A.
Machaczka, Maciej
Mengel, Eugen
Nagral, Aabha
Nakamura, Kimitoshi
Narita, Aya
Oliveri, María Beatriz
Pastores, Gregory
Pérez-López, Jordi
Ramaswami, Uma
Schwartz, Ida V.
Szer, Jeff
Weinreb, Neal J.
Zimran, Ari
author_role author
author2 Kuter, David J.
Salek, Sam S.
Belmatoug, Nadia
Bembi, Bruno
Bright, Jeremy
vom Dahl, Stephan
Deodato, Federica
Di Rocco, Maja
Göker Alpan, Ozlem
Hughes, Derralynn A.
Lukina, Elena A.
Machaczka, Maciej
Mengel, Eugen
Nagral, Aabha
Nakamura, Kimitoshi
Narita, Aya
Oliveri, María Beatriz
Pastores, Gregory
Pérez-López, Jordi
Ramaswami, Uma
Schwartz, Ida V.
Szer, Jeff
Weinreb, Neal J.
Zimran, Ari
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv ALGORITHM
INBORN ERROR
LYSOSOMAL STORAGE DISEASE
METABOLISM
SPLENOMEGALY
THROMBOCYTOPENIA
topic ALGORITHM
INBORN ERROR
LYSOSOMAL STORAGE DISEASE
METABOLISM
SPLENOMEGALY
THROMBOCYTOPENIA
purl_subject.fl_str_mv https://purl.org/becyt/ford/3.2
https://purl.org/becyt/ford/3
dc.description.none.fl_txt_mv Background: Gaucher disease (GD) presents with a range of signs and symptoms. Physicians can fail to recognise the early stages of GD owing to a lack of disease awareness, which can lead to significant diagnostic delays and sometimes irreversible but avoidable morbidities. Aim: The Gaucher Earlier Diagnosis Consensus (GED-C) initiative aimed to identify signs and co-variables considered most indicative of early type 1 and type 3 GD, to help non-specialists identify ‘at-risk’ patients who may benefit from diagnostic testing. Methods: An anonymous, three-round Delphi consensus process was deployed among a global panel of 22 specialists in GD (median experience 17.5 years, collectively managing almost 3000 patients). The rounds entailed data gathering, then importance ranking and establishment of consensus, using 5-point Likert scales and scoring thresholds defined a priori. Results: For type 1 disease, seven major signs (splenomegaly, thrombocytopenia, bone-related manifestations, anaemia, hyperferritinaemia, hepatomegaly and gammopathy) and two major co-variables (family history of GD and Ashkenazi-Jewish ancestry) were identified. For type 3 disease, nine major signs (splenomegaly, oculomotor disturbances, thrombocytopenia, epilepsy, anaemia, hepatomegaly, bone pain, motor disturbances and kyphosis) and one major co-variable (family history of GD) were identified. Lack of disease awareness, overlooking mild early signs and failure to consider GD as a diagnostic differential were considered major barriers to early diagnosis. Conclusion: The signs and co-variables identified in the GED-C initiative as potentially indicative of early GD will help to guide non-specialists and raise their index of suspicion in identifying patients potentially suitable for diagnostic testing for GD.
Fil: Mehta, Atul. University of California at Los Angeles; Estados Unidos
Fil: Kuter, David J.. Harvard Medical School; Estados Unidos
Fil: Salek, Sam S.. University Of Hertfordshire; Reino Unido
Fil: Belmatoug, Nadia. University Hospital Paris Nord Val de Seine.Referral Center for Lysosomal Diseases; Francia
Fil: Bembi, Bruno. Academic Medical Centre Hospital of Udine; Italia
Fil: Bright, Jeremy. Oxford PharmaGenesis Ltd. Research Evaluation Unit; Reino Unido
Fil: vom Dahl, Stephan. Heinrich-Heine University; Alemania
Fil: Deodato, Federica. Bambino Gesù Children’s Hospital; Italia
Fil: Di Rocco, Maja. Istituto Giannina Gaslini; Italia
Fil: Göker Alpan, Ozlem. No especifíca;
Fil: Hughes, Derralynn A.. University of California at Los Angeles; Estados Unidos
Fil: Lukina, Elena A.. National Research Center for Hematology; Rusia
Fil: Machaczka, Maciej. University Of Rzeszów; Polonia. Karolinska University Hospital Huddinge; Suecia
Fil: Mengel, Eugen. Johannes Gutenberg Universitat Mainz; Alemania
Fil: Nagral, Aabha. Apollo Hospital; India
Fil: Nakamura, Kimitoshi. Kumamoto University; Japón
Fil: Narita, Aya. Tottori University. Faculty Of Medicine; Japón
Fil: Oliveri, María Beatriz. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Inmunología, Genética y Metabolismo. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Inmunología, Genética y Metabolismo; Argentina
Fil: Pastores, Gregory. The Mater Misericordiae University Hospital; Irlanda
Fil: Pérez-López, Jordi. Hospital Vall d’Hebron; España
Fil: Ramaswami, Uma. Universidade Federal do Rio Grande do Sul; Brasil
Fil: Schwartz, Ida V.. Universidade Federal do Rio Grande do Sul; Brasil
Fil: Szer, Jeff. The Royal Melbourne Hospital; Australia
Fil: Weinreb, Neal J.. University of Miami; Estados Unidos
Fil: Zimran, Ari. Shaare Zedek Medical Center; Israel. Hadassah Medical School; Israel
description Background: Gaucher disease (GD) presents with a range of signs and symptoms. Physicians can fail to recognise the early stages of GD owing to a lack of disease awareness, which can lead to significant diagnostic delays and sometimes irreversible but avoidable morbidities. Aim: The Gaucher Earlier Diagnosis Consensus (GED-C) initiative aimed to identify signs and co-variables considered most indicative of early type 1 and type 3 GD, to help non-specialists identify ‘at-risk’ patients who may benefit from diagnostic testing. Methods: An anonymous, three-round Delphi consensus process was deployed among a global panel of 22 specialists in GD (median experience 17.5 years, collectively managing almost 3000 patients). The rounds entailed data gathering, then importance ranking and establishment of consensus, using 5-point Likert scales and scoring thresholds defined a priori. Results: For type 1 disease, seven major signs (splenomegaly, thrombocytopenia, bone-related manifestations, anaemia, hyperferritinaemia, hepatomegaly and gammopathy) and two major co-variables (family history of GD and Ashkenazi-Jewish ancestry) were identified. For type 3 disease, nine major signs (splenomegaly, oculomotor disturbances, thrombocytopenia, epilepsy, anaemia, hepatomegaly, bone pain, motor disturbances and kyphosis) and one major co-variable (family history of GD) were identified. Lack of disease awareness, overlooking mild early signs and failure to consider GD as a diagnostic differential were considered major barriers to early diagnosis. Conclusion: The signs and co-variables identified in the GED-C initiative as potentially indicative of early GD will help to guide non-specialists and raise their index of suspicion in identifying patients potentially suitable for diagnostic testing for GD.
publishDate 2019
dc.date.none.fl_str_mv 2019-05
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/116167
Mehta, Atul; Kuter, David J.; Salek, Sam S.; Belmatoug, Nadia; Bembi, Bruno; et al.; Presenting signs and patient co-variables in Gaucher disease: outcome of the Gaucher Earlier Diagnosis Consensus (GED-C) Delphi initiative; Wiley Blackwell Publishing, Inc; Internal Medicine Journal; 49; 5; 5-2019; 578-591
1444-0903
CONICET Digital
CONICET
url http://hdl.handle.net/11336/116167
identifier_str_mv Mehta, Atul; Kuter, David J.; Salek, Sam S.; Belmatoug, Nadia; Bembi, Bruno; et al.; Presenting signs and patient co-variables in Gaucher disease: outcome of the Gaucher Earlier Diagnosis Consensus (GED-C) Delphi initiative; Wiley Blackwell Publishing, Inc; Internal Medicine Journal; 49; 5; 5-2019; 578-591
1444-0903
CONICET Digital
CONICET
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/url/https://onlinelibrary.wiley.com/doi/abs/10.1111/imj.14156
info:eu-repo/semantics/altIdentifier/doi/10.1111/imj.14156
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by-nc-nd/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-nd/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv Wiley Blackwell Publishing, Inc
publisher.none.fl_str_mv Wiley Blackwell Publishing, Inc
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1844613091632873472
score 13.070432